Back to news

DFW Capital Partners is pleased to announce that its portfolio company Meta Pharmaceutical Services, LLC. (‘Meta’), a leading provider of outsourced marketing services to the pharmaceutical industry, has merged with NexGen RxMarketing, LLC (“NexGen”).

To facilitate the transaction, DFW invested growth capital in the form of preferred equity, and raised senior and subordinated debt financing.  Brian Tilley, a General Partner at DFW said, “We are excited about the combined capabilities of Meta and NexGen, and are fortunate to add talented executives to the team.  The combination will create a leading multi-channel marketing services and communications company, delivering highly targeted, high value add, data driven promotional products and services to the pharmaceutical industry.”

This merger is the result of an extensive search for a strategic partner who “would enhance and complement Meta’s service offerings, most critically in the area of digital delivery of messaging to healthcare professionals,” according to Thomas Lawrence, CEO of MetaPharm.

Headquartered in Blue Bell, PA with offices in Ewing, NJ, MetaPharm offers a comprehensive portfolio of data-driven multi-channel marketing services and analytics directed to healthcare providers.  Founded in 2000, MetaPharm has been recognized as one of the fastest growing companies in Inc. magazine and has served over 100 brands during its 13 year tenure.

Established in 2007, NexGen quickly established itself as a leader in technology-enabled solutions for increased access to healthcare professionals.  NexGen has developed two complementary, highly scalable multi-channel platforms that allow brands very cost-effective, optimized, measureable access to and communications with their professional audiences.

“Meta Pharm’s marketing automation expertise will allow us to offer increasingly targeted, personalized solutions resulting in greater access to healthcare providers for our customers”, said Chris Wiltshire of NexGen.

NexGen is headquartered in Bensalem, PA.

These two well-respected firms focus on customized, high-performance multi-channel solutions enabled by advanced technology.  Both have exemplary customer service and loyalty, exhibit industry expertise, in-depth knowledge, technical quality and cost competitiveness.

MetaPharm/NexGen will continue to operate independently with a broadened range of services to benefit the combined 70-plus healthcare brands they currently support.


About Meta Pharmaceutical Services, LLC

Meta Pharmaceutical Services, LLC. (‘Meta’) is a leading provider of outsourced data analysis, analytical tools and non-personal promotional services to the pharmaceutical industry. Meta delivers a suite of direct to physician communications programs to support field force selling efforts, and a suite of analytical services that gather information to generate actionable insights for marketing and sales teams and their partners. Meta’s products and services combine the company’s rich data analysis capabilities with direct mail fulfillment services creating a single source solution for non-personal promotion and marketing programs.

For more information, visit


About NexGen RxMarketing, LLC

NexGen RxMarketing, LLC (“NexGen”) is a technology-enabled digital communications provider for the healthcare industry.  NexGen combines technology focused products, scalable platforms, and enterprise-wide analytics to provide the next generation of efficient, closed-loop channels for delivering medical education content to healthcare providers.

For more information, visit


About DFW Capital Partners

DFW Capital Partners is a private equity investment firm focused on lower middle-market companies. The firm concentrates on service companies, with an emphasis on healthcare and outsourced business and industrial support services. DFW is backed by both institutional and high-net worth individual investors, and has established a 20+ year track record of success in building leading companies and delivering superior returns for its investors. DFW is headquartered in Teaneck, NJ, and maintains an office in Chevy Chase, MD. For more information contact Keith Pennell, Managing Partner, at (201) 836-6000.

Back to news